Chen 2006a.
Methods |
Groups: A: acupuncture, B: medicine control. Blinding: no information. Dropouts/withdrawals: 0. Duration of intervention: no information of baseline; 4 weeks' treatment; no follow‐up. |
|
Participants |
Number of participants screenings/included/analyzed: not reported/60/60. Number of participants in each group: 30:30 Demographics: aged 36‐65 years, mean age 54.75 years in A, aged 33‐61 years, mean age 51.72 years in B; number of women 10:9. Number of participants who used antihypertensive: no information. Course of disease: from 1 month to 10 years, mean 5.65 years in A; from 6.5 months to 10.42 years, mean 5.39 years in B Setting: inpatients from Department of Acupuncture and Moxibustion in the first hospital in Wuhan. |
|
Interventions |
Acupuncture points: Fengchi (bilateral). Information on acupuncturists: none. Deqi achieved?: yes. Control group intervention: metoprolol (25 mg pills, Batch number Su Wei medicine approved by 1985, 326201), 100 mg, once daily, at 8 a.m., for 4 weeks. |
|
Outcomes |
Primary outcome:
Secondary outcome:
|
|
Study detail |
Position for measuring BP: no information. BP measurements: no information. Time of each session: needles retained for 30 min, stimulated every 10 min. Number of treatment sessions: 28 (continuously for 4 weeks). Frequency of treatment sessions: no information, 2 weeks was a course. Time of recruiting: March 2004 to December 2004. Adverse events: no information. |
|
Publication detail |
Language of publication: Chinese. Commercial funding: no. Non‐commercial funding: yes (State administration of TCM). Publication status: peer review journal. |
|
Notes | Baseline BP: mean BP on 3 different days before treatment. Last BP: mean BP in last 3 days before ceasing treatment. |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Random number table. |
Allocation concealment (selection bias) | Unclear risk | No description. |
Blinding (performance bias and detection bias) All outcomes | High risk | Participants and investigators not blinded to acupuncture or pills. |
Incomplete outcome data (attrition bias) All outcomes | Low risk | No dropouts or exclusions from analysis. |
Selective reporting (reporting bias) | Low risk | Relevant outcomes reported. |
Other bias | Unclear risk | No description. |